|Articles|July 1, 2012
- Pharmaceutical Executive-07-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - July 2012
2012 Emerging Pharma Leaders
Advertisement
Articles in this issue
over 13 years ago
Emerging Pharma Leaders 2012over 13 years ago
Who Will Pay for New Drugs?over 13 years ago
Less, But Betterover 13 years ago
John Lechleiter on PhRMA and Innovationover 13 years ago
The Learning Curveover 13 years ago
Marketing: Why the Conversation Has Changed — ForeverNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
2
FDA Approves Yuvezzi to Treat Presbyopia in Adults
3
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
4
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
5